Details of the Drug

General Information of Drug (ID: DMUCW9Y)

Drug Name	Boronic acid derivative 5
Synonyms	PMID26413912-Compound-62
Drug Type	Small molecular drug
Structure
Structure	3D MOL	2D MOL
#Ro5 Violations (Lipinski): 0	Molecular Weight	281.1
	Logarithm of the Partition Coefficient	Not Available
	Rotatable Bond Count	4
	Hydrogen Bond Donor Count	2
	Hydrogen Bond Acceptor Count	3
Chemical Identifiers	Formula C16H16BNO3 IUPAC Name [1-oxo-2-(2-phenylethyl)-3H-isoindol-5-yl]boronic acid Canonical SMILES B(C1=CC2=C(C=C1)C(=O)N(C2)CCC3=CC=CC=C3)(O)O InChI InChI=1S/C16H16BNO3/c19-16-15-7-6-14(17(20)21)10-13(15)11-18(16)9-8-12-4-2-1-3-5-12/h1-7,10,20-21H,8-9,11H2 InChIKey OWKXCKRUGQYZKS-UHFFFAOYSA-N
Cross-matching ID	PubChem CID 46947813 TTD ID D05HJF

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Fatty acid amide hydrolase (FAAH)	TTDP1UC	NOUNIPROTAC	Inhibitor	[1]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

Molecule Name	Molecule Type	Gene Name	p-value	Fold-Change	Z-score
Fatty acid amide hydrolase (FAAH)	DTT	NO-GeName	2.65E-01	0.02	0.1

Molecular Expression Atlas (MEA)

Jump to Detail Molecular Expression Atlas of This Drug

References

1	Fatty acid amide hydrolase inhibitors: a patent review (2009-2014).Expert Opin Ther Pat. 2015;25(11):1247-66.